Affordable Access

Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.

Authors
  • Jarrett, R B1
  • Schaffer, M
  • McIntire, D
  • Witt-Browder, A
  • Kraft, D
  • Risser, R C
  • 1 Department of Psychiatry, The University of Texas Southwestern Medical Center at Dallas, 75235-9149, USA. [email protected]
Type
Published Article
Journal
Archives of General Psychiatry
Publisher
American Medical Association
Publication Date
May 01, 1999
Volume
56
Issue
5
Pages
431–437
Identifiers
PMID: 10232298
Source
Medline
License
Unknown

Abstract

Cognitive therapy may offer an effective alternative to standard acute-phase treatment with a monoamine oxidase inhibitor for outpatients with major depressive disorder and atypical features.

Report this publication

Statistics

Seen <100 times